Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
105,021,048
-
Total 13F shares
-
71,894,248
-
Share change
-
+6,036,805
-
Total reported value
-
$6,474,592,585
-
Put/Call ratio
-
78%
-
Price per share
-
$90.05
-
Number of holders
-
326
-
Value change
-
+$536,221,296
-
Number of buys
-
166
-
Number of sells
-
123
Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock (SRPT) as of Q4 2021
As of 31 Dec 2021,
Sarepta Therapeutics, Inc. - Common Stock (SRPT) was held by
326 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
71,894,248 shares.
The largest 10 holders included
VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, SANDS CAPITAL MANAGEMENT, LLC, BlackRock Inc., Avoro Capital Advisors LLC, FMR LLC, Bank of New York Mellon Corp, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, and Casdin Capital, LLC.
This page lists
326
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.